Cargando…
A Novel Indoline Derivative Ameliorates Diabesity-Induced Chronic Kidney Disease by Reducing Metabolic Abnormalities
Both diabetes and obesity (diabesity) contribute significantly to the development of chronic kidney disease (CKD). In search of new remedies to reverse or arrest the progression of CKD, we examined the therapeutic potential of a novel compound, AN1284, in a mouse model of CKD induced by type 2 diabe...
Autores principales: | Permyakova, Anna, Gammal, Asaad, Hinden, Liad, Weitman, Michal, Weinstock, Marta, Tam, Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7078689/ https://www.ncbi.nlm.nih.gov/pubmed/32218769 http://dx.doi.org/10.3389/fendo.2020.00091 |
Ejemplares similares
-
The Metabolic Efficacy of a Cannabidiolic Acid (CBDA) Derivative in Treating Diet- and Genetic-Induced Obesity
por: Ben-Cnaan, Elad, et al.
Publicado: (2022) -
The relationship between sugar-sweetened beverages, sleep disorders, and diabesity
por: Zhang, Yi, et al.
Publicado: (2023) -
CB(1)R regulates soluble leptin receptor levels via CHOP, contributing to hepatic leptin resistance
por: Drori, Adi, et al.
Publicado: (2020) -
Peripheral Cannabinoid-1 Receptor Blockade Ameliorates Cystitis Severity
por: Hinden, Liad, et al.
Publicado: (2023) -
Kidney Proximal Tubule GLUT2—More than Meets the Eye
por: Ahmad, Majdoleen, et al.
Publicado: (2022)